WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

Ketoconazole

Identifier

024063

Type of Spiritual Experience

Hallucination

Number of hallucinations: 39

Background

A description of the experience

Ketoconazole (INN, USAN, BAN, JAN) is a synthetic imidazole antifungal drug used primarily to treat fungal infections. Ketoconazole is sold commercially as a tablet for oral administration (although this use has been discontinued in a number of countries), and in a variety of formulations for topical administration, such as creams (used to treat tinea; cutaneous candidiasis, including candidal paronychia; and pityriasis versicolor) and shampoos (used primarily to treat dandruff—seborrhoeic dermatitis of the scalp).

The less toxic and generally more effective triazole antifungal agents fluconazole and itraconazole are usually preferred for systemic use. In 2013 the European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP) recommended that a ban be imposed on the use of oral ketoconazole for systemic use in humans throughout the European Union, after concluding that the risk of serious liver injury from systemic ketoconazole outweighs its benefits. The oral formulation of ketoconazole was discontinued in Australia in 2013 and in China in 2015.

Most common Ketoconazole side effects from eHealthme

  • Fatigue - (388 reports)
  • Pain - (363 reports)
  • Nausea - (350 reports)
  • Weakness - (341 reports)
  • Breathing difficulty - (320 reports)
  • Stress and anxiety - (309 reports)
  • Anaemia - (274 reports)
  • Rashes - (269 reports)
  • Diarrhea - (256 reports)
  • Dizziness - (246 reports)

On Jan, 24, 2017  4,436 people reported to have side effects when taking Ketoconazole.  Among them, 34 people (0.77%) have Hallucination

On Feb, 07, 2017  4,436 people reported to have side effects when taking Ketoconazole.  Among them, 5 people (0.11%) have Hallucination, Auditory

 

On Jan, 18, 2017  4,436 people reported to have side effects when taking Ketoconazole.  Among them, 139 people (3.13%) have Death

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Fungal infection treatments

Commonsteps

References